Filing Details
- Accession Number:
- 0001227025-21-000248
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-08 18:30:25
- Reporting Period:
- 2021-11-04
- Accepted Time:
- 2021-11-08 18:30:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1227025 | Neophotonics Corp | NPTN | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1209534 | J Michael Sophie | 3081 Zanker Rd San Jose CA 95134 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-11-04 | 5,228 | $8.56 | 29,050 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-11-04 | 5,228 | $15.04 | 23,822 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-11-04 | 12,160 | $15.04 | 11,662 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-11-04 | 5,228 | $15.04 | 5,228 | $8.56 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
3,732 | 2030-06-01 | No | 4 | M | Direct |
Footnotes
- Sale pursuant to a trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- This option shall vest ratably at a rate of 1/12th of the total number of shares granted on each monthly anniversary of the grant date, so long as the Reporting Person remains a member of the Board of Directors of the Company.